QQ客服 官方微博 反馈留言

	Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial
	Solomon, Scott D.; Rizkala, Adel R.; Gong, Jianjian; Wang, Wenyan; Anand, Inder S.; Ge, Junbo; Lam, Carolyn S. P.; Maggioni, Aldo P.; Martinez, Felipe; Packer, Milton
刊名	JACC-HEART FAILURE
	2017
卷号	5期号:7
ISSN号	2213-1779
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3615979
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Solomon, Scott D.,Rizkala, Adel R.,Gong, Jianjian,et al. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial[J]. JACC-HEART FAILURE,2017,5(7).
APA	Solomon, Scott D..,Rizkala, Adel R..,Gong, Jianjian.,Wang, Wenyan.,Anand, Inder S..,...&McMurray, John J. V..(2017).Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial.JACC-HEART FAILURE,5(7).
MLA	Solomon, Scott D.,et al."Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial".JACC-HEART FAILURE 5.7(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。